Latham & Watkins has advised Novo Holdings A/S (Novo) on a €25 million extended Series C financing for AMSilk GmbH (AMSilk), the world’s first industrial supplier of bio-fabricated silk protein materials. Novo is investing alongside existing investors ATHOS (AT Newtec) and MIG Capital. The financing will enable AMSilk to accelerate industrial scale and expand commercial operations of bio-engineered silk protein materials.
Latham & Watkins has already regularly advised Novo on a number of investments in the past, including Novo’s first investment in AMSilk two years ago. The Series C financing of €29 million has now been extended to €54 million.
The Latham team was led by Hamburg partner Henning C. Schneider, with partner Dirk Kocher and associate Katarina Fröschle.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
